IQVIA

IQVIA

Life Sciences Tools & Services
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

$44.8B

Market Cap • 11/6/2026

2016

(10 years)

Founded

2013

(13 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

6,7

P/S

2,6

P/EBITDA

13

P/OCF

16,4

P/FCF

21,5

P/E

33

BVPS

40,4

EPS

8,2

Market Cap

Market Cap

44,8B

EV

58,8B

EV/Revenue

3,4

EV/EBITDA

17,1

EV/EBIT

26,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

2,7%

Total Yield

2,7%

Payout

0%

Retained Earnings

8,3B

Profitability

Gross Margin

33,1%

EBITDA Margin

19,9%

EBIT Margin

12,8%

Net Margin

7,5%

D&A/EBITDA

35,4%

R&D/Revenue

0%

Capex/Revenue

3,8%

Capex/D&A

53,9%

Capex/OCF

24%

SBC/OCF

11,1%

% PPE

2,8%

% Goodwill

55,5%

ROE

19,8%

ROIC

7,4%

Growth

CAGR Revenue 5Y

5%

CAGR Op. Income 5Y

12,7%

CAGR Net Income 5Y

10,8%

CAGR EPS 5Y

15,9%

CAGR OCF 5Y

-1,8%

Leverage

N.D./EBITDA

4

Debt/Equity

0%

Current Ratio

0,8

Quick Ratio

0,7

Interest Coverage

282,7%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium